LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
$ 398,000
Convenience Stores & Lotto Businesses For Sale
Consulting & Training Businesses for Sale
Coin Laundry & Dry Cleaning Businesses for Sale
Gift & Flower Shops for Sale
Farms & Vineyards for Sale
Automotive Businesses for Sale
Transport & Shipping Businesses for Sale
Grocery Stores & Delis for Sale
Retirement Homes for Sale
Digital Marketing Business for Sale
Coffee, Bakery & Dessert Franchise Opportunities
Wholesale & Distribution Franchise Opportunities
Beauty & Personal Care Franchises for Sale
Gas Station & Car Wash Franchises for Sale
Senior Care Franchise for Sale
Smoke & Vape Shop Franchises for Sale
Miscellaneous Franchises for Sale
Home Based Franchise Opportunities
Construction & Landscaping Franchise Opportunities
Clothing & Shoe Store Franchise Opportunities
Places of Worship for Sale
Land & Developments for Sale
Commercial Buildings for Sale or Lease
Warehouses for Sale or Lease
Industrial Units for Sale or Rent
Houses & Condos for Sale or Lease
Commercial Spaces for Sale or Lease
Office Buildings for Sale or Rent
Retail Buildings for Sale or Lease
Industrial Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: